Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Plos Pathogens|August 7, 2018
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumorsValerio Leoni, Andrea Vannini, Valentina Gatta, et al.
International Journal of Molecular Sciences|June 26, 2025
Alteration of Lipid Metabolism in Patients with IPF and Its Association with Disease Severity and Prognosis: A Case-Control StudyPaola Faverio, Paola Rebora, Giovanni Franco, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 7, 2022
Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infectionLucia Salvioni, Filippo Testa, Adela Sulejmani, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 15, 2019
Antiviral oxysterols are present in human milk at diverse stages of lactationAndrea Civra, Valerio Leoni, Claudio Caccia, et al.
Human Molecular Genetics|July 7, 2007
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutationMarta Valenza, Jeffrey B Carroll, Valerio Leoni, et al.
Endocrine-Related Cancer|July 25, 2015
4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomasLuca Varinelli, Dario Caccia, Chiara C Volpi, et al.
Neuroscience Letters|June 30, 2009
Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's diseaseAlina Solomon, Valerio Leoni, Miia Kivipelto, et al.
Molecules (Basel, Switzerland)|September 14, 2019
Octadecaneuropeptide (ODN) Induces N2a Cells Differentiation through a PKA/PLC/PKC/MEK/ERK-Dependent Pathway: Incidence on Peroxisome, Mitochondria, and Lipid ProfilesAmira Namsi, Thomas Nury, Amira S Khan, et al.
Cell Metabolism|May 13, 2014
NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial diseaseRaffaele Cerutti, Eija Pirinen, Costanza Lamperti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 2011
Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's diseaseZhongmin Xiang, Marta Valenza, Libin Cui, et al.
Pageof 14